Aurinia Pharmaceuticals Inc. Other Assets, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Current $1.38M.
- 2026-03-31: Other Assets, Current $1.76M.
- 2025-12-31: Other Assets, Current $1.08M.
- 2025-09-30: Other Assets, Current $301.00K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $1.38M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.76M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.08M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $301.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $665.00K 10-Q · filed 2025-07-31 |
| 2025-03-31 | $781.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.13M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.70M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $6.98M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $2.00M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.03M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.65M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $1.21M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.23M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.33M 10-K · filed 2024-02-15 |
| 2022-09-30 | $3.81M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.09M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.97M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $796.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $728.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $886.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.18M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.02M 10-K · filed 2022-02-28 |